Catheter ablation is fast becoming one of the safest and most effective treatments for atrial fibrillation (AF) as new technologies become increasingly available to treat a […]

CHICAGO — A randomized placebo-controlled trial testing a direct oral anticoagulant for the prevention of cognitive decline in patients with atrial fibrillation (AF) has been halted […]

CHICAGO — Edoxaban, a direct oral anticoagulant, appeared to be as effective as or more effective than warfarin in preventing thromboembolism — such as stroke, systemic […]

A small number of potentially game-changing trials in Europe and around the world could be on the verge of identifying, for the first time, a medical […]

The addition of linear ablation plus ethanol infusion to pulmonary vein isolation (PVI) improves control of persistent atrial fibrillation (AF) better than PVI alone, a multicenter […]

A left atrial appendage (LAA) closure device provides long-term thromboembolic protection that is equivalent to direct oral anticoagulants after ablation for atrial fibrillation (AF), along with […]

The routine administration of spironolactone to patients after a myocardial infarction (MI) did not reduce either of the coprimary outcomes in the CLEAR SYNERGY (OASIS 9) […]

A simple, lightweight device worn on the sternum can calculate intracardiac filling pressures, warning that heart failure is worsening, according to a study conducted to determine […]